Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Cd3e monoclonal antibody, clone 500-A2 (FITC)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Mouse |
| Host species | Hamster |
| Applications | IP,Flow Cyt |
More info about Cd3e monoclonal antibody, clone 500-A2 (FITC)
| Brand: | Abnova |
| Reference: | MAB5912 |
| Product name: | Cd3e monoclonal antibody, clone 500-A2 (FITC) |
| Product description: | Hamster monoclonal antibody raised against Cd3e. |
| Clone: | 500-A2 |
| Isotype: | IgG, kappa |
| Gene id: | 12501 |
| Gene name: | Cd3e |
| Gene alias: | AI504783|CD3|CD3epsilon|T3e |
| Gene description: | CD3 antigen, epsilon polypeptide |
| Immunogen: | Mouse T cell receptor complexes. |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (3 ug/106 cells) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store in the dark at 4°C. Do not freeze. Avoid prolonged exposure to light. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Conjugate tag: | FITC |
| Product type: | Primary antibodies |
| Host species: | Hamster |
| Antigen species / target species: | Mouse |
| Specificity: | Mouse CD3ε, Mr 25 KDa. |
| Reactivity: | Mouse |
| Applications: | IP,Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.Portoles P, Rojo J, Golby A, Bonneville M, Gromkowski S, Greenbaum L, Janeway CA Jr, Murphy DB, Bottomly K. J Immunol. 1989 Jun 15;142(12):4169-75. |